Kashentseva EA - Search Results

1

Development of an adenovirus vector vaccine platform for targeting dendritic cells.

Sharma PK, Dmitriev IP, Kashentseva EA, Raes G, Li L, Kim SW, Lu ZH, Arbeit JM, Fleming TP, Kaliberov SA, Goedegebuure SP, Curiel DT, Gillanders WE. Sharma PK, et al. Among authors: kashentseva ea. Cancer Gene Ther. 2018 Feb;25(1-2):27-38. doi: 10.1038/s41417-017-0002-1. Epub 2017 Dec 15. Cancer Gene Ther. 2018. PMID: 29242639 Free PMC article.

2

[Immunologic indicators in vaccinated mice with Machupo virus infection].

Patrusheva IV, Kaliberov SA, Kashentseva EA, Ignat'ev GM. Patrusheva IV, et al. Among authors: kashentseva ea. Vopr Virusol. 1997 May-Jun;42(3):137-40. Vopr Virusol. 1997. PMID: 9297347 Russian.

3

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel DT. Dmitriev I, et al. J Virol. 1998 Dec;72(12):9706-13. doi: 10.1128/JVI.72.12.9706-9713.1998. J Virol. 1998. PMID: 9811704 Free PMC article.

4

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.

Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Dmitriev I, et al. J Virol. 2000 Aug;74(15):6875-84. doi: 10.1128/jvi.74.15.6875-6884.2000. J Virol. 2000. PMID: 10888627 Free PMC article.

5

Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.

Krasnykh V, Dmitriev I, Navarro JG, Belousova N, Kashentseva E, Xiang J, Douglas JT, Curiel DT. Krasnykh V, et al. Cancer Res. 2000 Dec 15;60(24):6784-7. Cancer Res. 2000. PMID: 11156365 Review.

6

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.

Wesseling JG, Bosma PJ, Krasnykh V, Kashentseva EA, Blackwell JL, Reynolds PN, Li H, Parameshwar M, Vickers SM, Jaffee EM, Huibregtse K, Curiel DT, Dmitriev I. Wesseling JG, et al. Among authors: kashentseva ea. Gene Ther. 2001 Jul;8(13):969-76. doi: 10.1038/sj.gt.3301473. Gene Ther. 2001. PMID: 11438831

7

Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines.

Seki T, Dmitriev I, Kashentseva E, Takayama K, Rots M, Suzuki K, Curiel DT. Seki T, et al. J Virol. 2002 Feb;76(3):1100-8. doi: 10.1128/jvi.76.3.1100-1108.2002. J Virol. 2002. PMID: 11773386 Free PMC article.

8

Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain.

Kashentseva EA, Seki T, Curiel DT, Dmitriev IP. Kashentseva EA, et al. Cancer Res. 2002 Jan 15;62(2):609-16. Cancer Res. 2002. PMID: 11809717

9

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

Dmitriev IP, Kashentseva EA, Curiel DT. Dmitriev IP, et al. Among authors: kashentseva ea. J Virol. 2002 Jul;76(14):6893-9. doi: 10.1128/jvi.76.14.6893-6899.2002. J Virol. 2002. PMID: 12072490 Free PMC article.

10

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.

Seki T, Dmitriev I, Suzuki K, Kashentseva E, Takayama K, Rots M, Uil T, Wu H, Wang M, Curiel DT. Seki T, et al. Gene Ther. 2002 Aug;9(16):1101-8. doi: 10.1038/sj.gt.3301815. Gene Ther. 2002. PMID: 12140738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page